Most discussions about a GMP inspection focus on documents and SOP structures. But when regulators walk into a GxP lab, they are also assessing whether trained staff can clearly explain and demonstrate how work is done in practice.
In complex research, small technique differences can lead to batch failures, OOS results, or knowledge transfer delays. Recurring deviations often point to gaps in GxP training. For teams in regulated environments, pharma audit readiness starts long before any formal inspection finding appears.